{"id":"W1994693894","doi":"10.1158/1538-7445.am2014-ct205","title":"Abstract CT205: A phase I dose-escalation study of trametinib (T) in combination with continuous or intermittent GSK2126458 (GSK458) in patients (pts) with advanced solid tumors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tolerability; Rash; Dosing; Internal medicine; Vomiting; Gastroenterology; Mucositis; Adverse effect; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006451909,0.001041843,0.001157606,0.0003813097,0.0003295015,0.0007777684,0.0006036886,0.0006982733,0.004008207],"category_scores_gemma":[0.0004592717,0.0004420878,0.0009839358,0.0005259768,0.0005779713,0.0005803057,0.0002168562,0.002063254,0.0008225113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008955628,"about_ca_system_score_gemma":0.001562456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001711919,"about_ca_topic_score_gemma":0.005040588,"domain_scores_codex":[0.9998068,0.00008202958,0.00001292565,0.00003238581,0.00002282485,0.00004306172],"domain_scores_gemma":[0.9996927,0.00003405963,0.00006262142,0.00001937634,0.00001846427,0.0001728617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6845175,0.05217737,0.007722166,0.001722253,0.00126337,0.0005023055,0.0003516428,0.005671646,0.1213116,0.0003934158,0.006023184,0.1183436],"study_design_scores_gemma":[0.3337595,0.6331151,0.01727757,0.0000600332,0.0005391931,0.00064288,0.00009583018,0.002388851,0.008718464,0.0001534692,0.003198987,0.0000501622],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949433,0.001085438,0.0003315563,0.000232811,0.00006424044,0.001042892,0.0007935673,0.0001039472,0.001402188],"genre_scores_gemma":[0.9942914,0.0008396933,0.0006998752,0.0002811282,0.00006223741,0.0007218111,0.00110679,0.00001482286,0.001982312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004008207,"threshold_uncertainty_score":0.01340878,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03212406334622851,"score_gpt":0.388988129606175,"score_spread":0.3568640662599464,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}